


REGEXBIO Revenue
Pharmaceutical Manufacturing • • 1-10 Employees
REGEXBIO revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at REGEXBIO
Philippa Whiteside
Director and Principal, Regulatory Affairs and Development
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Development, CMC, Global, Regulatory Affairs, Biologics, Technical Writing, Cmc Consulting, Post-Approval, Initial Licensing, Dossier Architecture |
| Founded | 2009 |
| Employees | 1-10 |
REGEXBIO Email Formats
REGEXBIO uses 1 email format. The most common is {first initial} (e.g., j@regexbio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@regexbio.com | 100% |
About REGEXBIO
REGEXBIO provides REGulatory EXpertise in BIOlogicals for the development of your biopharmaceutical. Key deliverables on your CMC timeline are heavily influenced by regulatory requirements. These can be generated to a high quality and right first time by applying knowledge and experience of working in the area both within the Chemistry Manufacturing and Control (CMC) and Regulatory Affairs (RA) functions. Every technical Subject Matter Expert will have some regulatory knowledge, and some regulatory experts may have some technical knowledge. Bridging these two knowledge bases (orange overlap below) can provide invaluable input on your product development, and a seamless interface in the interpretation of CMC data for the delivery of strategy, gap analyses, technical reports and dossier.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
REGEXBIO has never raised funding before.
Frequently asked questions
4.8
40,000 users



